137 related articles for article (PubMed ID: 33231912)
1. Process economics evaluation of cell-free synthesis for the commercial manufacture of antibody drug conjugates.
Stamatis C; Farid SS
Biotechnol J; 2021 Apr; 16(4):e2000238. PubMed ID: 33231912
[TBL] [Abstract][Full Text] [Related]
2. Evaluating end-to-end continuous antibody manufacture with column-free capture alternatives from economic, environmental, and robustness perspectives.
Neves CPG; Coffman JL; Farid SS
Biotechnol Prog; 2024 Jan; ():e3427. PubMed ID: 38289674
[TBL] [Abstract][Full Text] [Related]
3. Optimising the design and operation of semi-continuous affinity chromatography for clinical and commercial manufacture.
Pollock J; Bolton G; Coffman J; Ho SV; Bracewell DG; Farid SS
J Chromatogr A; 2013 Apr; 1284():17-27. PubMed ID: 23453463
[TBL] [Abstract][Full Text] [Related]
4. Process economics of industrial monoclonal antibody manufacture.
Farid SS
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 848(1):8-18. PubMed ID: 16899415
[TBL] [Abstract][Full Text] [Related]
5. Integrated continuous bioprocessing: Economic, operational, and environmental feasibility for clinical and commercial antibody manufacture.
Pollock J; Coffman J; Ho SV; Farid SS
Biotechnol Prog; 2017 Jul; 33(4):854-866. PubMed ID: 28480535
[TBL] [Abstract][Full Text] [Related]
6. Decisional tool for cost of goods analysis of bioartificial liver devices for routine clinical use.
Mendonça da Silva J; Stamatis C; Chalmers SA; Erro E; Selden C; Farid SS
Cytotherapy; 2021 Aug; 23(8):683-693. PubMed ID: 34116945
[TBL] [Abstract][Full Text] [Related]
7. Containment challenges in HPAPI manufacture for ADC generation.
Dunny E; O'Connor I; Bones J
Drug Discov Today; 2017 Jun; 22(6):947-951. PubMed ID: 28279788
[TBL] [Abstract][Full Text] [Related]
8. Conjugation process development and scale-up.
Stump B; Steinmann J
Methods Mol Biol; 2013; 1045():235-48. PubMed ID: 23913151
[TBL] [Abstract][Full Text] [Related]
9. Analytical Comparison of Antibody-drug Conjugates Based on Good Manufacturing Practice Strategies.
Tawfiq Z; Matsuda Y; Alfonso MJ; Clancy C; Robles V; Leung M; Mendelsohn BA
Anal Sci; 2020 Jul; 36(7):871-875. PubMed ID: 32336726
[TBL] [Abstract][Full Text] [Related]
10. Development and Evaluation of a Fluorescent Antibody-Drug Conjugate for Molecular Imaging and Targeted Therapy of Pancreatic Cancer.
Knutson S; Raja E; Bomgarden R; Nlend M; Chen A; Kalyanasundaram R; Desai S
PLoS One; 2016; 11(6):e0157762. PubMed ID: 27336622
[TBL] [Abstract][Full Text] [Related]
11. Real-Time Analysis on Drug-Antibody Ratio of Antibody-Drug Conjugates for Synthesis, Process Optimization, and Quality Control.
Tang Y; Tang F; Yang Y; Zhao L; Zhou H; Dong J; Huang W
Sci Rep; 2017 Aug; 7(1):7763. PubMed ID: 28798339
[TBL] [Abstract][Full Text] [Related]
12. Fed-batch and perfusion culture processes: economic, environmental, and operational feasibility under uncertainty.
Pollock J; Ho SV; Farid SS
Biotechnol Bioeng; 2013 Jan; 110(1):206-19. PubMed ID: 22806692
[TBL] [Abstract][Full Text] [Related]
13. Sensitive ELISA Method for the Measurement of Catabolites of Antibody-Drug Conjugates (ADCs) in Target Cancer Cells.
Salomon PL; Singh R
Mol Pharm; 2015 Jun; 12(6):1752-61. PubMed ID: 25738394
[TBL] [Abstract][Full Text] [Related]
14. Rational design, biophysical and biological characterization of site-specific antibody-tubulysin conjugates with improved stability, efficacy and pharmacokinetics.
Thompson P; Fleming R; Bezabeh B; Huang F; Mao S; Chen C; Harper J; Zhong H; Gao X; Yu XQ; Hinrichs MJ; Reed M; Kamal A; Strout P; Cho S; Woods R; Hollingsworth RE; Dixit R; Wu H; Gao C; Dimasi N
J Control Release; 2016 Aug; 236():100-16. PubMed ID: 27327768
[TBL] [Abstract][Full Text] [Related]
15. A Two-Step Immunocapture LC/MS/MS Assay for Plasma Stability and Payload Migration Assessment of Cysteine-Maleimide-Based Antibody Drug Conjugates.
Dong L; Li C; Locuson C; Chen S; Qian MG
Anal Chem; 2018 May; 90(10):5989-5994. PubMed ID: 29688004
[TBL] [Abstract][Full Text] [Related]
16. Total Synthesis in Search of Potent Antibody-Drug Conjugate Payloads. From the Fundamentals to the Translational.
Nicolaou KC; Rigol S
Acc Chem Res; 2019 Jan; 52(1):127-139. PubMed ID: 30575399
[TBL] [Abstract][Full Text] [Related]
17. Development of novel anti-CD19 antibody-drug conjugates for B-cell lymphoma treatment.
Li Z; Wang M; Yao X; Li H; Li S; Liu L; Yu D; Li X; Fang J; Huang C
Int Immunopharmacol; 2018 Sep; 62():299-308. PubMed ID: 30048860
[TBL] [Abstract][Full Text] [Related]
18. A Reactive Antibody Platform for One-Step Production of Antibody-Drug Conjugates through a Diels-Alder Reaction with Maleimide.
St Amant AH; Huang F; Lin J; Lemen D; Chakiath C; Mao S; Fazenbaker C; Zhong H; Harper J; Xu W; Patel N; Adams L; Vijayakrishnan B; Howard PW; Marelli M; Wu H; Gao C; Read de Alaniz J; Christie RJ
Bioconjug Chem; 2019 Sep; 30(9):2340-2348. PubMed ID: 31380623
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic cell therapy bioprocess economics and optimization: downstream processing decisions.
Hassan S; Simaria AS; Varadaraju H; Gupta S; Warren K; Farid SS
Regen Med; 2015; 10(5):591-609. PubMed ID: 26237703
[TBL] [Abstract][Full Text] [Related]
20. Preclinical Evaluation of
Hartimath SV; Alizadeh E; Solomon VR; Chekol R; Bernhard W; Hill W; Parada AC; Barreto K; Geyer CR; Fonge H
J Nucl Med; 2019 Aug; 60(8):1103-1110. PubMed ID: 30655327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
